CRISPR-Cas Immunity against Phages: Its Effects on the Evolution and Survival of Bacterial Pathogens

PLoS Pathogens

Volumn 9, Issue 12, 2013, Pages 1-4

  Marraffini, Luciano A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; NUCLEASE; TOLL LIKE RECEPTOR 2; VIRULENCE FACTOR; CRISPR ASSOCIATED PROTEIN;

ADAPTIVE IMMUNITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BIOGENESIS; CAMPYLOBACTER JEJUNI; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; EVOLUTION; FRANCISELLA NOVICIDA; GENE EXPRESSION; GENE LOCUS; GENETIC VARIABILITY; HORIZONTAL GENE TRANSFER; IMMUNOMODULATION; LEGIONELLA PNEUMOPHILA; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN CLEAVAGE; STREPTOCOCCUS PNEUMONIAE; VIRUS INFECTION; BACTERIAL GENE; BACTERIOPHAGE; BACTERIUM; GENE TARGETING; GENETICS; IMMUNOLOGY; INTERSPERSED REPEAT; MICROBIAL VIABILITY; MOLECULAR EVOLUTION; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

BACTERIA; BACTERIOPHAGES; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEINS; EVOLUTION, MOLECULAR; GENE TARGETING; GENES, BACTERIAL; INTERSPERSED REPETITIVE SEQUENCES; MICROBIAL VIABILITY;

EID: 84892846048     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003765     Document Type: Article

References (47)

1. Bikard D, Marraffini LA, (2012) Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages. Curr Opin Immunol 24: 15-20.
2. Westra ER, Swarts DC, Staals RH, Jore MM, Brouns SJ, et al. (2012) The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity. Annu Rev Genet 46: 311-339.
3. Wiedenheft B, Sternberg SH, Doudna JA, (2012) RNA-guided genetic silencing systems in bacteria and archaea. Nature 482: 331-338.
4. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, et al. (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315: 1709-1712.
5. Cady KC, Bondy-Denomy J, Heussler GE, Davidson AR, O'Toole GA, (2012) The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J Bacteriol 194: 5728-5738.
6. Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, et al. (2008) Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321: 960-964.
7. Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, et al. (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468: 67-71.
8. Datsenko KA, Pougach K, Tikhonov A, Wanner BL, Severinov K, et al. (2012) Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun 3: 945.
9. Yosef I, Goren MG, Qimron U, (2012) Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res 40: 5569-5576.
10. Carte J, Wang R, Li H, Terns RM, Terns MP, (2008) Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev 22: 3489-3496.
11. Haurwitz RE, Jinek M, Wiedenheft B, Zhou K, Doudna JA, (2010) Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 329: 1355-1358.
12. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
13. Westra ER, van Erp PB, Kunne T, Wong SP, Staals RH, et al. (2012) CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell 46: 595-605.
14. Grissa I, Vergnaud G, Pourcel C, (2007) The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 8: 172.
15. Chakraborty S, Snijders AP, Chakravorty R, Ahmed M, Tarek AM, et al. (2010) Comparative network clustering of direct repeats (DRs) and cas genes confirms the possibility of the horizontal transfer of CRISPR locus among bacteria. Mol Phylogenet Evol 56: 878-887.
16. Godde JS, Bickerton A, (2006) The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes. J Mol Evol 62: 718-729.
17. Bikard D, Hatoum-Aslan A, Mucida D, Marraffini LA, (2012) CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 12: 177-186.
18. Fischer S, Maier LK, Stoll B, Brendel J, Fischer E, et al. (2012) An archaeal immune system can detect multiple Protospacer Adjacent Motifs (PAMs) to target invader DNA. J Biol Chem 287: 33351-33363.
19. Gudbergsdottir S, Deng L, Chen Z, Jensen JV, Jensen LR, et al. (2011) Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers. Mol Microbiol 79: 35-49.
20. Jiang W, Maniv I, Arain F, Wang Y, Levin BR, et al. (2013) Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. PLoS Genet 9: e1003844 doi:10.1371/journal.pgen.1003844.
21. Brodt A, Lurie-Weinberger MN, Gophna U, (2011) CRISPR loci reveal networks of gene exchange in archaea. Biol Direct 6: 65.
22. Horvath P, Coute-Monvoisin AC, Romero DA, Boyaval P, Fremaux C, et al. (2009) Comparative analysis of CRISPR loci in lactic acid bacteria genomes. Int J Food Microbiol 131: 62-70.
23. Stern A, Keren L, Wurtzel O, Amitai G, Sorek R, (2010) Self-targeting by CRISPR: gene regulation or autoimmunity? Trends Genet 26: 335-340.
24. Thomas CM, Nielsen KM, (2005) Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nat Rev Microbiol 3: 711-721.
25. Erdmann S, Garrett RA, (2012) Selective and hyperactive uptake of foreign DNA by adaptive immune systems of an archaeon via two distinct mechanisms. Mol Microbiol 85: 1044-1056.
26. Marraffini LA, Sontheimer EJ, (2008) CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322: 1843-1845.
27. Lopez-Sanchez MJ, Sauvage E, Da Cunha V, Clermont D, Ratsima Hariniaina E, et al. (2012) The highly dynamic CRISPR1 system of Streptococcus agalactiae controls the diversity of its mobilome. Mol Microbiol 85: 1057-1071.
28. Zhang Y, Heidrich N, Ampattu BJ, Gunderson CW, Seifert HS, et al. (2013) Processing-Independent CRISPR RNAs Limit Natural Transformation in Neisseria meningitidis. Mol Cell 50: 488-503.
29. Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, et al. (2011) Rapid pneumococcal evolution in response to clinical interventions. Science 331: 430-434.
30. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, et al. (2003) Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302: 1569-1571.
31. Bisno AL, Brito MO, Collins CM, (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3: 191-200.
32. Nozawa T, Furukawa N, Aikawa C, Watanabe T, Haobam B, et al. (2011) CRISPR inhibition of prophage acquisition in Streptococcus pyogenes. PLoS ONE 6: e19543 doi:10.1371/journal.pone.0019543.
33. Furuya EY, Lowy FD, (2006) Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol 4: 36-45.
34. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, et al. (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187: 2426-2438.
35. Touchon M, Charpentier S, Pognard D, Picard B, Arlet G, et al. (2012) Antibiotic resistance plasmids spread among natural isolates of Escherichia coli in spite of CRISPR elements. Microbiology 158: 2997-3004.
36. Golding GR, Bryden L, Levett PN, McDonald RR, Wong A, et al. (2010) Livestock-associated methicillin-resistant Staphylococcus aureus sequence type 398 in humans, Canada. Emerg Infect Dis 16: 587-594.
37. Holt DC, Holden MT, Tong SY, Castillo-Ramirez S, Clarke L, et al. (2011) A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol 3: 881-895.
38. Palmer KL, Gilmore MS, (2010) Multidrug-resistant enterococci lack CRISPR-cas. mBio 1: e00227-00210.
39. Griffith F, (1928) The significance of pneumococcal types. J Hyg 27: 113-159.
40. Gunderson FF, Cianciotto NP, (2013) The CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae. mBio 4: e00074-00013.
41. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, et al. (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471: 602-607.
42. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA, (2013) RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31: 233-239.
43. Jones CL, Sampson TR, Nakaya HI, Pulendran B, Weiss DS, (2012) Repression of bacterial lipoprotein production by Francisella novicida facilitates evasion of innate immune recognition. Cell Microbiol 14: 1531-1543.
44. Sampson TR, Saroj SD, Llewellyn AC, Tzeng YL, Weiss DS, (2013) A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497: 254-257.
45. Sampson TR, Saroj SD, Llewellyn AC, Tzeng YL, Weiss DS, (2013) Corrigendum: a CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 501: 262.
46. Louwen R, Horst-Kreft D, de Boer AG, van der Graaf L, de Knegt G, et al. (2013) A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barre syndrome. Eur J Clin Microbiol Infect Dis 32: 207-226.
47. Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR, (2013) Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493: 429-432.